George Farmer
Stock Analyst at Scotiabank
(2.64)
# 2,442
Out of 5,182 analysts
70
Total ratings
50%
Success rate
4.46%
Average return
Main Sectors:
Top Industries:
Stocks Rated by George Farmer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMEA Biomea Fusion | Maintains: Sector Outperform | $30 → $10 | $1.73 | +478.03% | 4 | Aug 6, 2025 | |
| ACLX Arcellx | Maintains: Sector Outperform | $93 → $133 | $115.07 | +15.58% | 4 | Jul 31, 2025 | |
| INMB INmune Bio | Downgrades: Sector Underperform | $23 → $0.6 | $1.47 | -59.18% | 3 | Jul 1, 2025 | |
| URGN UroGen Pharma | Maintains: Sector Outperform | $23 → $47 | $23.77 | +97.73% | 1 | Jun 13, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Sector Perform | $16 → $17 | $21.00 | -19.05% | 4 | May 6, 2025 | |
| TARA Protara Therapeutics | Initiates: Sector Outperform | $12 | $4.99 | +140.48% | 1 | Apr 16, 2025 | |
| TPST Tempest Therapeutics | Downgrades: Sector Perform | $91 → $9 | $1.72 | +423.26% | 4 | Apr 10, 2025 | |
| JANX Janux Therapeutics | Maintains: Sector Perform | $62 → $41 | $15.23 | +169.21% | 4 | Feb 28, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Sector Outperform | $47 → $52 | $30.45 | +70.77% | 4 | Feb 27, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Sector Perform | $78 → $80 | $53.81 | +48.69% | 8 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $244 → $224 | $180.67 | +23.98% | 4 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $102 | $32.99 | +209.23% | 1 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $18 → $10 | $9.07 | +10.25% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Sector Outperform | $439 → $715 | $783.74 | -8.77% | 5 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $20 → $23 | $6.96 | +230.46% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $20 | $1.06 | +1,786.79% | 1 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $70 → $76 | $23.65 | +221.35% | 4 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $13 | $4.85 | +168.04% | 1 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $109 | $48.70 | +123.82% | 3 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $94 → $87 | $95.72 | -9.11% | 5 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $2.83 | +1,066.08% | 1 | Oct 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $400 | $9.98 | +3,908.02% | 1 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $27 | $44.65 | -39.53% | 3 | May 6, 2020 |
Biomea Fusion
Aug 6, 2025
Maintains: Sector Outperform
Price Target: $30 → $10
Current: $1.73
Upside: +478.03%
Arcellx
Jul 31, 2025
Maintains: Sector Outperform
Price Target: $93 → $133
Current: $115.07
Upside: +15.58%
INmune Bio
Jul 1, 2025
Downgrades: Sector Underperform
Price Target: $23 → $0.6
Current: $1.47
Upside: -59.18%
UroGen Pharma
Jun 13, 2025
Maintains: Sector Outperform
Price Target: $23 → $47
Current: $23.77
Upside: +97.73%
Syndax Pharmaceuticals
May 6, 2025
Maintains: Sector Perform
Price Target: $16 → $17
Current: $21.00
Upside: -19.05%
Protara Therapeutics
Apr 16, 2025
Initiates: Sector Outperform
Price Target: $12
Current: $4.99
Upside: +140.48%
Tempest Therapeutics
Apr 10, 2025
Downgrades: Sector Perform
Price Target: $91 → $9
Current: $1.72
Upside: +423.26%
Janux Therapeutics
Feb 28, 2025
Maintains: Sector Perform
Price Target: $62 → $41
Current: $15.23
Upside: +169.21%
NewAmsterdam Pharma Company
Feb 27, 2025
Maintains: Sector Outperform
Price Target: $47 → $52
Current: $30.45
Upside: +70.77%
BioMarin Pharmaceutical
Feb 20, 2025
Maintains: Sector Perform
Price Target: $78 → $80
Current: $53.81
Upside: +48.69%
Feb 13, 2025
Maintains: Sector Outperform
Price Target: $244 → $224
Current: $180.67
Upside: +23.98%
Feb 13, 2025
Initiates: Sector Outperform
Price Target: $102
Current: $32.99
Upside: +209.23%
Jan 8, 2025
Maintains: Sector Perform
Price Target: $18 → $10
Current: $9.07
Upside: +10.25%
Nov 5, 2024
Upgrades: Sector Outperform
Price Target: $439 → $715
Current: $783.74
Upside: -8.77%
Oct 18, 2024
Maintains: Sector Outperform
Price Target: $20 → $23
Current: $6.96
Upside: +230.46%
Sep 30, 2024
Initiates: Sector Outperform
Price Target: $20
Current: $1.06
Upside: +1,786.79%
Aug 12, 2024
Maintains: Sector Outperform
Price Target: $70 → $76
Current: $23.65
Upside: +221.35%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $4.85
Upside: +168.04%
Nov 17, 2020
Downgrades: Market Perform
Price Target: $109
Current: $48.70
Upside: +123.82%
Nov 6, 2020
Maintains: Market Perform
Price Target: $94 → $87
Current: $95.72
Upside: -9.11%
Oct 27, 2020
Initiates: Outperform
Price Target: $33
Current: $2.83
Upside: +1,066.08%
Jul 20, 2020
Initiates: Outperform
Price Target: $400
Current: $9.98
Upside: +3,908.02%
May 6, 2020
Maintains: Market Perform
Price Target: $20 → $27
Current: $44.65
Upside: -39.53%